Cymabay Therapeutics, Inc.
Records under this name other than the patents Cymabay Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.
Back to Cymabay Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,098,843 | Compositions of 5-Ethyl-2-{4-[4-(4-Tetrazol-1-YL-PHENOXYMETHYL)-THIAZOL-2-YL]-PIPERIDIN-1-YL}-PYRIMIDINE Lapsed on the fee record Ended Oct 16, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 16, 2026 | Low confidence |
| US 8,815,886 | Substituted TETRAZOL-1-YL-PHENOXYMETHYL-THIAZOL-2-YL-PIPERIDINYL-PYRIMIDINE Salts held by Metabolex, Inc. Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 9,925,189 | Heterocyclic Receptor Agonists for the Treatment of Diabetes and Metabolic Disorders Lapsed on the fee record Ended Mar 27, 2026 · Medium confidence | Lapsed on the fee record | Ended Mar 27, 2026 | Medium confidence |
| US 8,541,614 | Process for the Preparation of (-)-(4-Chloro-PHENYL)-(3-Trifluoromethyl-PHENOXY)-ACETIC Acid 2-Acetylamino-ETHYL Ester now held by Diatex, Inc. Lapsed on the fee record Ended Sep 24, 2025 · High confidence | Lapsed on the fee record | Ended Sep 24, 2025 | High confidence |
| US 9,737,537 | Heterocyclic Receptor Agonists for the Treatment of Diabetes and Metabolic Disorders Lapsed on the fee record Ended Aug 22, 2025 · Medium confidence | Lapsed on the fee record | Ended Aug 22, 2025 | Medium confidence |
| US 7,323,480 | Substituted Triazoles as Modulators of Ppar and Methods of Their Preparation Term ended Term ended May 24, 2025 · High confidence | Term ended | Term ended May 24, 2025 | High confidence |
| US 8,410,127 | Substituted TETRAZOL-1-YL-PHENOXYMETHYL-THIAZOL-2-YL-PIPERIDINYL-PYRIMIDINE Salts Lapsed on the fee record Ended Apr 2, 2025 · High confidence | Lapsed on the fee record | Ended Apr 2, 2025 | High confidence |
| US 8,288,384 | Heterocyclic Receptor Agonists for the Treatment of Diabetes and Metabolic Disorders Lapsed on the fee record Ended Oct 16, 2024 · Medium confidence | Lapsed on the fee record | Ended Oct 16, 2024 | Medium confidence |
| US 8,227,495 | 2,4-Disubsituted Thiazoles and Pharmaceutical Compositions Thereof Lapsed on the fee record Ended Jul 24, 2024 · Medium confidence | Lapsed on the fee record | Ended Jul 24, 2024 | Medium confidence |
| US 7,199,259 | Resolution of Alpha-(PHENOXY)phenylacetic Acid Derivatives now held by Diatex, Inc. Term ended Term ended Apr 17, 2024 · High confidence | Term ended | Term ended Apr 17, 2024 | High confidence |